|
NSUN2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.198300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.045600E-02 |
| Normal-vs-Stage2 |
6.188800E-01 |
| Normal-vs-Stage3 |
1.114170E-01 |
| Normal-vs-Stage4 |
1.584360E-01 |
| Stage1-vs-Stage2 |
4.404400E-01 |
| Stage1-vs-Stage3 |
9.681800E-01 |
| Stage1-vs-Stage4 |
8.014600E-01 |
| Stage2-vs-Stage3 |
4.939400E-01 |
| Stage2-vs-Stage4 |
4.497800E-01 |
| Stage3-vs-Stage4 |
8.444200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.927600E-02 |
| Normal-vs-AfricanAmerican |
8.592600E-04 |
| Normal-vs-Asian |
1.879010E-01 |
| Caucasian-vs-AfricanAmerican |
3.880500E-02 |
| Caucasian-vs-Asian |
7.905000E-01 |
| AfricanAmerican-vs-Asian |
5.077500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.052000E-01 |
| Normal-vs-Female |
1.815800E-02 |
| Male-vs-Female |
2.980600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.710500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.856200E-03 |
| Normal-vs-Age(61-80Yrs) |
5.070400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.902220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.880200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.467600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.026780E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.102100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.714300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.151600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.181800E-03 |
| Classical-VS-Follicular |
4.084300E-02 |
| Classical-VS-Other |
3.038200E-01 |
| Classical-VS-Normal |
4.598400E-01 |
| Tall-VS-Follicular |
1.778030E-01 |
| Tall-VS-Other |
6.875600E-01 |
| Tall-VS-Normal |
3.338900E-03 |
| Follicular-VS-Other |
7.512600E-01 |
| Follicular-VS-Normal |
2.561500E-02 |
| Other-VS-Normal |
3.074200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.523580E-02 |
| Normal-vs-N1 |
6.127200E-01 |
| N0-vs-N1 |
3.691200E-01 |
|
|
